Captain T Cell GmbH
PrivateLast Round
Series A
Nov 17, 2025
Total Funding Raised
$9.19M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Captain T Cell GmbH is a biotechnology company that develops next-generation T-cell therapies against solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Captain T Cell GmbH Comparables
Compare Captain T Cell GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T-knife Therapeutics | 87% | |
| Anocca | 81% | |
| ALKemist Bio | 81% |
Captain T Cell GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 17, 2025 | ||||
| Seed | May 22, 2024 |
Key People
Founding team and executive leadership
Captain T Cell GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Series A, Seed |
| Sintra Limited | Series A |
| CFH Management | Series A |
| Ascenion | Seed |
| Brandenburg Kapital | Series A, Seed |
| Springboard Health Angels | Series A |
| i&i Prague | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Grew 133% QoQ from 6 to 14 employees.
- Nov 17, 2025
Raised Series A led by Springboard Health Angels.
Captain T Cell GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access